Bayer, Reynaldo .

HRN: 26-57-20  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/21/2025
CEFTAZIDIME 1GM (VIAL)
01/21/2025
01/28/2025
IVTT
1 Gm
Q12h
Fracture, Open, Comminuted, Middle 3rd Tibia & Fibula
Waiting Final Action 
01/21/2025
CEFAZOLIN 1GM (VIAL)
01/21/2025
01/28/2025
IV
1g
Every 8 Hours
Open Fracture
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: